StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a report released on Monday. The brokerage set a “hold” rating on the stock.
China Pharma Price Performance
Shares of China Pharma stock opened at $0.22 on Monday. The business’s fifty day simple moving average is $0.23 and its 200 day simple moving average is $0.31. China Pharma has a 12 month low of $0.17 and a 12 month high of $1.77. The company has a current ratio of 0.89, a quick ratio of 0.25 and a debt-to-equity ratio of 0.17.
China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) EPS for the quarter. The business had revenue of $0.93 million for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Recommended Stories
- Five stocks we like better than China Pharma
- 3 Warren Buffett Stocks to Buy Now
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- Transportation Stocks Investing
- MarketBeat Week in Review – 8/19 – 8/23
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
